Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response

Ruiz Malagón, Antonio Jesús; Hidalgo García, Laura; Rodríguez Sojo, María Jesús; Molina Tijeras, José Alberto; Díez Echave, Patricia; Vezza, Teresa; Rodríguez Cabezas, María Elena; Rodríguez Nogales, Alba; Gálvez Peralta, Julio Juan

doi:10.1016/j.biopha.2023.114760

1-s2.0-S0753332223005498-main.pdf (12.27Mo)

Identificadores

URI: https://hdl.handle.net/10481/82946

DOI: 10.1016/j.biopha.2023.114760

Exportar

Editorial

Elsevier

Materia

Colitis-associated colorectal cancer

Tigecycline

β-catenin

Cytotoxic T lymphocytes

Microbiota

Date

2023-04-27

Referencia bibliográfica

A.J. Ruiz-Malagón et al. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomedicine & Pharmacotherapy 163 (2023) 114760[https://doi.org/10.1016/j.biopha.2023.114760]

Patrocinador

Junta de Andalucía (CTS 164); Instituto de Salud Carlos III (Spain); Fondo Europeo de Desarrollo Regional (FEDER); European Union, through the research grants PI18/00826, P18-RT-4930, PI0206–2016, PIE16/00045 and PI19/01058; Spanish Ministry of Science and Innovation (MCIN/AEI/ 10.13039/501100011033/FEDER); RTI2018–101309-BC22; Chair “Doctors Galera-Requena in cancer stem cell research” (CMC-CTS963; Spanish Ministry of Science and Innovation (“Programa de Doctorado: Medicina Clínica y Salud Pública” B12.56.1).; Instituto de Salud Carlos III (FI17/00176); Junta de Andalucía (P18-RT-4930); University of Granada; CIBER-EHD is funded by the Instituto de Salud Carlos III

Colecciones

DF - Artículos

Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional